ESOP/ESOS/ESPS

September 04, 2026 To To The Manager, Listing Department The General Manager, Listing Department National Stock Exchange of India Ltd. BSE Limited Plot no. C/1 G Block, Phiroze Jeejeebhoy Towers, Bandra-Kurla Complex, Bandra (East), Dalal Street, Mumbai- 400 051 Mumbai- 400 001 Symbol: BLISSGVS Scrip Code: 506197 Dear Sir/Madam, Subject: Allotment of Shares under Bliss GVS Pharma Limited – Employee Stock Options Plan, 2019 We like to inform you that the ESOP Allotment Committee of the Company, at its meeting held today i.e. September 04, 2026, has approved the allotment of 55,250 equity shares of the face value of Re. 1/- each to the eligible employee who has exercised their stock options under Bliss GVS Pharma Limited–Employee Stock Option Plan 2019 (‘Bliss GVS ESOP-2019’). Consequent to the aforesaid allotment, issued, subscribed & paid-up share capital of the Company has increased as under: From To 10,62,75,223 equity shares of Re. 1/- each 10,63,30,472 equity shares of Re. 1/- each aggregating Rs. 10,62,75,223/- aggregating Rs. 10,63,30,472/- In terms of Regulation 10(c) of the SEBI (Share Based Employee Benefits and Sweat Equity) Regulations, 2021 the details of shares allotted as above are given in ‘Annexure-I’ to this intimation. Kindly take the above information on record. Thank you. Yours faithfully, For Bliss GVS Pharma Limited Aditi Bhatt Company Secretary Encl: As above ‘Annexure – I’ Regulation 10(c) of the SEBI (Share Based Employee Benefits and Sweat Equity) Regulations, 2021 Company Name and address of Registered Bliss GVS Pharma Limited Office Add: 102, Hyde Park, Saki Vihar Road, Andheri (East), Mumbai - 400072 Name of the Stock Exchanges on which the BSE Limited Company’s shares are listed The National Stock Exchange of India Limited Filing date of the statement referred in 14/02/2020 regulation 10(b) of the SEBI (Share Based Employee Benefits) Regulations, 2014 read with the SEBI (Share Based Employee Benefits and Sweat Equity) Regulations, 2021 with the recognized Stock Exchange Filing Number, if any Application No: BSE – 106063 NSE – 23188 In-Principle Approval Letter: BSE: DCS/FL/DS/ESOP-IP/542/2019-20 dated February 27, 2020 NSE: NSE/LIST/23188 dated March 04, 2020 Title of the Scheme pursuant to which Bliss GVS Pharma Limited–Employee Stock shares are issued, if any Option Plan, 2019 Kind of security to be listed Equity Shares Par value of the shares Re. 1/- per share Date of issue of shares September 04, 2026 Number of shares issued 55,250 Share Certificate No., if applicable Not Applicable Distinctive number of the share, if 10,62,75,223 to 10,63,30,472 (both inclusive) applicable ISIN Number of the shares if issued in INE416D01022 Demat Exercise price per share Rs. 43/- per share Premium per share Rs. 42/- per share Total Issued shares after this issue 10,63,30,472 Total Issued share capital after this issue Rs. 10,63,30,472/- Details of any lock-in on the shares Lock in for a period of 6 (six) months from the date of allotment of Equity Shares. Date of expiry of lock-in March 03, 2027 Whether shares are identical in all respects All equity shares of the Company allotted to existing shares, if not, when will they pursuant to the exercise of stock options become identical? shall rank pari passu with the existing equity shares of the Company Details of listing fees, if payable Not applicable